Differences between neonates and adults in carbohydrate sequences and reaction kinetics of plasmin and alpha(2)-antiplasmin.

This study investigates reaction kinetics by slow-binding kinetics methods of both adult and fetal plasmin (Types 1 and 2) with adult and fetal alpha(2)-antiplasmin. In addition, carbohydrate sequences of Fetal and Adult Plasminogen Types 1 and 2, as well as fetal and adult alpha(2)-antiplasmin, were determined by mass spectrometric analysis. All curves of plasmin-alpha(2)-antiplasmin interaction followed the same pattern, indicating reversible slow-binding inhibition with an initial loose complex and a following tight complex. Differences between fetal and adult plasmin reactions with alpha(2)-antiplasmin were predominantly due to the initial loose complex. Values for K(i initial) in the reaction with adult alpha(2)-antiplasmin were 1.5 and 1.6 nM for Fetal Plasmin Types 1 and 2, respectively; compared to 0.3 and 0.7 nM for the corresponding adult types. Increasing concentrations of tranexamic acid resulted in a continuous increase of K(i initial) until a plateau was reached which was similar for all plasmin types. Almost identical values could be obtained when fetal alpha(2)-antiplasmin was used instead of adult alpha(2)-antiplasmin. Mass spectrometric analyses of the glycans present on plasminogen revealed a higher level of truncated N-glycans on the fetal material compared to the adult. The O-glycans of fetal and adult plasminogen were closely similar and only minor differences were observed between N-glycans of fetal and adult alpha(2)-antiplasmin. In conclusion, both fetal plasmin isoforms are less inhibited by alpha(2)-antiplasmin compared to the adult plasmin variants. These findings are important for the understanding of the physiology of the fibrinolytic system in neonates and provide further evidence that differences in glycosylation could be associated with marked effects on protein function.

[1]  L. Summaria Comparison of human normal, full-term, fetal and adult plasminogen by physical and chemical analyses. , 1989, Haemostasis.

[2]  M. Andrew Developmental Hemostasis: Relevance to Thromboembolic Complications in Pediatric Patients , 1995, Thrombosis and Haemostasis.

[3]  M. Ries,et al.  Molecular and Functional Properties of Fetal Plasminogen and Its Possible Influence on Clot Lysis in the Neonatal Period , 1997, Seminars in thrombosis and hemostasis.

[4]  I. Nilsson,et al.  FIBRINOLYSIS IN NEWBORNS , 1970, Acta paediatrica Scandinavica.

[5]  J. Enghild,et al.  Evidence for a Novel O-Linked Sialylated Trisaccharide on Ser-248 of Human Plasminogen 2* , 1997, The Journal of Biological Chemistry.

[6]  J. Gilabert,et al.  Dysfunctional Plasminogen in Full Term Newborn - Study of Active Site of Plasmin , 1984, Thrombosis and Haemostasis.

[7]  M. Zenker,et al.  Age‐Related Differences in a Clot Lysis Assay After Adding Different Plasminogen Activators in a Plasma Milieu in Vitro , 1995, Journal of pediatric hematology/oncology.

[8]  M. Fukuda,et al.  Glycobiology : a practical approach , 1993 .

[9]  F. Castellino,et al.  Role of lysine binding regions in the kinetic properties of human plasmin. , 1981, Biochemistry.

[10]  D. Deutsch,et al.  Plasminogen: Purification from Human Plasma by Affinity Chromatography , 1970, Science.

[11]  I. Clemmensen,et al.  Enzymic properties of the neo-plasmin-Val-422 (miniplasmin). , 1979, Biochimica et biophysica acta.

[12]  Donald J. Nevins,et al.  A method for the analysis of sugars in plant cell-wall polysaccharides by gas-liquid chromatography , 1967 .

[13]  J. Gilabert,et al.  Dysfunctional Plasminogen in Full-Term Newborn , 1980, Pediatric Research.

[14]  A. Dell,et al.  Differences between neonates and adults in tissue-type-plasminogen activator (t-PA)-catalyzed plasminogen activation with various effectors and in carbohydrate sequences of fibrinogen chains. , 2001, Thrombosis research.

[15]  B. Wiman,et al.  On the kinetics of the reaction between human antiplasmin and a low-molecular-weight form of plasmin. , 1978, European journal of biochemistry.

[16]  I. Clemmensen,et al.  Kinetic properties of the primary inhibitor of plasmin from human plasma. , 1977, The Biochemical journal.

[17]  B. Wiman,et al.  On the kinetics of the reaction between human antiplasmin and plasmin. , 1978, European journal of biochemistry.

[18]  P. Gaffney,et al.  Serpin-serine protease binding kinetics: alpha 2-antiplasmin as a model inhibitor. , 1991, Biochemistry.

[19]  P. McKee,et al.  Characterization of wild-type and mutant alpha2-antiplasmins: fibrinolysis enhancement by reactive site mutant. , 1999, Blood.

[20]  S. Thorsen,et al.  Reaction of human α2‐antiplasmin and plasmin Stopped‐flow fluorescence kinetics , 1996 .

[21]  J. Klinge,et al.  The role of alpha 2-antiplasmin in the inhibition of clot lysis in newborns and adults. , 1996, Biology of the neonate.

[22]  M. Zenker,et al.  Differences between neonates and adults in the urokinase-plasminogen activator (u-PA) pathway of the fibrinolytic system. , 2000, Thrombosis research.

[23]  G. W. Jameson,et al.  Determination of the operational molarity of solutions of bovine alpha-chymotrypsin, trypsin, thrombin and factor Xa by spectrofluorimetric titration. , 1971, The Biochemical journal.

[24]  M. Zenker,et al.  In Vitro Fibrinolysis After Adding Low Doses of Plasminogen Activators and Plasmin Generation with and without Oxidative Inactivation of Plasmin Inhibitors in Newborns and Adults , 1996, Journal of pediatric hematology/oncology.

[25]  J. Enghild,et al.  Neonatal plasminogen displays altered cell surface binding and activation kinetics. Correlation with increased glycosylation of the protein. , 1990, The Journal of clinical investigation.

[26]  L. L. Phillips,et al.  A comparison of the fibrinolytic enzyme system in maternal and umbilical-cord blood. , 1958, Pediatrics.

[27]  M. L. Hayes,et al.  Carbohydrate of the human plasminogen variants. II. Structure of the asparagine-linked oligosaccharide unit. , 1979, The Journal of biological chemistry.

[28]  E. Ruoslahti,et al.  Structure of the carbohydrate units of human amniotic fluid fibronectin. , 1985, The Journal of biological chemistry.

[29]  H. Lijnen,et al.  Basic and Clinical Aspects of Fibrinolysis and Thrombolysis , 1991 .

[30]  S. Reif,et al.  Alteration in the regulation of plasma membrane glycoproteins of the hepatocyte during ontogeny. , 1990, Experimental cell research.

[31]  B. Wiman Affinity-chromatographic purification of human α2-antiplasmin , 1980 .

[32]  I. Clemmensen,et al.  Purification and reaction mechanisms of the primary inhibitor of plasmin from human plasma. , 1978, The Biochemical journal.

[33]  M. L. Hayes,et al.  Carbohydrate of the human plasminogen variants. III. Structure of the O-glycosidically linked oligosaccharide unit. , 1979, The Journal of biological chemistry.

[34]  F. Castellino,et al.  Measurement of the binding of antifibrinolytic amino acids to various plasminogens. , 1972, Archives of biochemistry and biophysics.

[35]  M. L. Hayes,et al.  Carbohydrate of the human plasminogen variants. I. Carbohydrate composition, glycopeptide isolation, and characterization. , 1979, The Journal of biological chemistry.